Patent · US Active

Anti-TAT188 antibodies

US7749504B2 · kind B2 · utility

16Cited by

214References

23Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Belinda Cairns · Burlingame, US
Ruihuan Chen · Meekrap-oord, CN
Gretchen Frantz · San Francisco, US
Kenneth Hillan · San Francisco, US
Hartmut Koeppen · San Mateo, US
Heidi Phillips · South San Francisco, US
Paul Polakis · Mill Valley, US
Susan D. Spencer · Tiburon, US
Victoria Smith · Burlingame, US
P. Williams · Rue de l'Église, US
Thomas Wu · San Francisco, US
Zemin Zhang · Foster City, US

Key dates

Filing date	Apr 11, 2007
Grant date	Jul 6, 2010
Priority date	—
Expiry date	Sep 3, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.